An interesting study in adult patients with arrhythmogenic right ventricular cardiomyopathy by Oz et al. [44] and implanted defibrillators adds to the evidence for galectin-3 being useful in the risk stratification of arrhythmias. Here, LGALS3 is linked to Arrhythmogenic right ventricular dysplasia.